&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2025-05-19, 23:15

Global phase III trials demonstrate that nerandomilast slowed lung function decline in IPF and PPF, with similar discontinuation rates to placebo

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2025-01-16, 22:05

Boehringer provides update on iclepertin Phase III program in schizophrenia
Cassie Shields

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-11-04, 20:57

Philips enrolls first patient in U.S. clinical trial for innovative integrated single-device to treat peripheral artery disease
Basil Slack

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-11-01, 01:22

Sabin Sends More Marburg Vaccines for Rwanda’s Outbreak
Lavon Hort

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-09-09, 22:45

Boehringer’s zongertinib shows encouraging efficacy and tolerability profile in previously treated HER2 mutated lung cancer patients

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-07-15, 21:29

Sabin Vaccine Institute Begins Phase 2 Clinical Trial for Sudan Ebolavirus Vaccine

Popular Posts